Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation
.

Durand A, Tauber M, Patel B, Dutailly P.

Horm Res Paediatr. 2017;87(4):224-232. doi: 10.1159/000456545. Epub 2017 Mar 23.

PMID:
28334719
2.

Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Uttley L, Whyte S, Gomersall T, Ren S, Wong R, Chambers D, Tappenden P.

Pharmacoeconomics. 2017 Jul;35(7):717-726. doi: 10.1007/s40273-016-0481-1. Review.

PMID:
27943135
3.

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.

Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S.

Cochrane Database Syst Rev. 2015 Nov 9;(11):CD006919. doi: 10.1002/14651858.CD006919.pub4. Review.

PMID:
26558801
4.

Anti-Hormonal Therapies for Premenopausal Patients--What did we Learn from the TEXT/SOFT Trials?

Valsecchi ME, Recondo G, de la Vega M, Greco M, Recondo G, Díaz Cantón E.

Rev Recent Clin Trials. 2015;10(2):90-100. Review.

PMID:
26216437
5.

Dienogest in the treatment of endometriosis: systematic review.

Andres Mde P, Lopes LA, Baracat EC, Podgaec S.

Arch Gynecol Obstet. 2015 Sep;292(3):523-9. doi: 10.1007/s00404-015-3681-6. Epub 2015 Mar 8. Review.

PMID:
25749349
6.

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.

Kunath F, Grobe HR, Rücker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ.

Cochrane Database Syst Rev. 2014 Jun 30;(6):CD009266. doi: 10.1002/14651858.CD009266.pub2. Review.

PMID:
24979481
7.

Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.

Lin H, Li Y, Li L, Wang W, Yang D, Zhang Q.

PLoS One. 2014 Mar 18;9(3):e91796. doi: 10.1371/journal.pone.0091796. eCollection 2014.

8.

Aromatase inhibitors for uterine fibroids.

Song H, Lu D, Navaratnam K, Shi G.

Cochrane Database Syst Rev. 2013 Oct 23;(10):CD009505. doi: 10.1002/14651858.CD009505.pub2. Review.

PMID:
24151065
9.

Direct androgen regulation of PDE5 gene or the lack thereof.

Lin CS, Xin Z, Namiki M, Albersen M, Muller D, Lue TF.

Int J Impot Res. 2013 May;25(3):81-5. doi: 10.1038/ijir.2013.11. Epub 2013 Mar 14. Review.

PMID:
23486196
10.

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.

Maheshwari A, Gibreel A, Siristatidis CS, Bhattacharya S.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD006919. doi: 10.1002/14651858.CD006919.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD006919.

PMID:
21833958
11.

Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.

Ferrero S, Gillott DJ, Venturini PL, Remorgida V.

Reprod Biol Endocrinol. 2011 Jun 21;9:89. doi: 10.1186/1477-7827-9-89. Review.

12.

Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy.

Iannazzo S, Pradelli L, Carsi M, Perachino M.

Value Health. 2011 Jan;14(1):80-9. doi: 10.1016/j.jval.2010.10.023.

13.

Use of hormonal protection for chemotherapy-induced gonadotoxicity.

Kim SS, Lee JR, Jee BC, Suh CS, Kim SH, Ting A, Petroff B.

Clin Obstet Gynecol. 2010 Dec;53(4):740-52. doi: 10.1097/GRF.0b013e3181f96cb1. Review.

PMID:
21048441
14.

Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Oliveira JB, Baruffi R, Petersen CG, Mauri AL, Cavagna M, Franco JG Jr.

Reprod Biol Endocrinol. 2010 Sep 8;8:107. doi: 10.1186/1477-7827-8-107. Review.

15.

Impact of surgical and medical castration on serum testosterone level in prostate cancer patients.

Novara G, Galfano A, Secco S, Ficarra V, Artibani W.

Urol Int. 2009;82(3):249-55. doi: 10.1159/000209352. Epub 2009 May 11. Review.

PMID:
19440008
16.

Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.

Briken P, Hill A, Berner W.

J Clin Psychiatry. 2003 Aug;64(8):890-7. Review.

PMID:
12927003
17.

Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.

Sowter MC, Lethaby A, Singla AA.

Cochrane Database Syst Rev. 2002;(3):CD001124. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD001124.

PMID:
12137619
18.

GnRH antagonist in assisted reproduction: a Cochrane review.

Al-Inany H, Aboulghar M.

Hum Reprod. 2002 Apr;17(4):874-85.

PMID:
11925376
19.

Gonadotrophin-releasing hormone antagonists for assisted conception.

Al-Inany H, Aboulghar M.

Cochrane Database Syst Rev. 2001;(4):CD001750. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001750.

PMID:
11687120
20.

Efficacy of nafarelin in assisted reproductive technology: a meta-analysis.

Wong JM, Forrest KA, Snabes SZ, Zhao SZ, Gersh GE, Kennedy SH.

Hum Reprod Update. 2001 Jan-Feb;7(1):92-101.

PMID:
11212082

Supplemental Content

Loading ...
Support Center